Endothelial nitric oxide synthase polymorphisms and hypertension

Area of Science:

• Genetics and Molecular Biology
• Cardiovascular Physiology
• Reproductive Medicine

Background:

• The human endothelial nitric oxide synthase (eNOS) gene exhibits significant polymorphism.
• Limited evidence links eNOS single nucleotide polymorphisms (SNPs) to essential hypertension.
• The eNOS Glu298Asp polymorphism's impact on endothelial function and vascular adaptation is under investigation.

Purpose of the Study:

• To investigate the role of eNOS gene polymorphisms in essential hypertension.
• To explore the influence of the eNOS Glu298Asp variant on blood pressure regulation and endothelial function.
• To assess the association between the eNOS Asp298 allele and pregnancy-related vascular complications like pre-eclampsia.

Main Methods:

• Analysis of eNOS gene polymorphisms, specifically the Glu298Asp variant.
• Assessment of blood pressure response to exercise in relation to eNOS genotype.
• Evaluation of endothelial function and its modulation by the eNOS Asp298 allele.
• Molecular studies examining eNOS protein activity and proteolysis.

Main Results:

• The eNOS Glu298Asp polymorphism influences blood pressure response to exercise.
• This variant impacts endothelial function, particularly during pregnancy's vascular adaptations.
• Carriers of the eNOS Asp298 allele may have an increased risk of pre-eclampsia.
• Molecular studies suggest reduced steady-state levels of active eNOS in Asp298 carriers due to proteolysis.

Conclusions:

• The eNOS Glu298Asp polymorphism is associated with altered blood pressure regulation and endothelial function.
• Carriers of the eNOS Asp298 allele may be predisposed to pre-eclampsia and other vascular diseases.
• Environmental factors interacting with the eNOS Asp298 allele might elevate risks for atherosclerosis and cerebrovascular disease.